TC BioPharm (Holdings) PLC (TCBP)
1.46
+0.01
(+0.69%)
USD |
NASDAQ |
May 03, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 2.218M |
| September 30, 2021 | 2.211M |
| Date | Value |
|---|---|
| December 31, 2020 | 2.068M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.068M
Minimum
Dec 2020
2.218M
Maximum
Dec 2021
2.166M
Average
2.211M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 33.21M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 8.519M |
| Autolus Therapeutics PLC | 25.16M |
| Mereo BioPharma Group PLC | -- |